Qazi Nasreen, Khan Rafeeq Alam, Rizwani Ghazala H
Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.
Department of Pharmacology, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan.
Pak J Pharm Sci. 2015 May;28(3):991-5.
Nowadays anxiety and depression are most commonly encountered diseases. They are not only difficult to diagnose but even difficult to treat since both are sometimes seen together or one predisposes the other. Apart from this side effect profile of these drugs is also high; hence there is immense scope for the herbal drugs to treat these disorders. Present study was therefore performed to evaluate the antianxiety and antidepressant effect of Carthamus tinctorius petal extract. 28 white albino rats bred in the animal house of Department of Pharmacology, University of Karachi weighing 180-220gm were randomly divided into four groups (n=7/group) to assess behavioral effects. The anxiolytic and antidepressant effects of Carthamus tinctorius petal extract were evaluated using elevated plus maize and forced swim test respectively at100 and 200mg/kg. These effects were compared with standard drugs Diazepam (anxiolytic) 2mg/kg and Nortriptyline (antidepressant) 12.5mg/kg. Results show that CT produced highly significant anxiolytic and anti-depressant effects at both doses as compared to control, similar to standard anxiolytic and antidepressant drugs diazepam and nortriptyline. It increased the latency of first entry to closed arms and the time spent in open arms very significantly at both doses while entries to open arm were increased significantly at 100mg/kg and very significantly at 200mg/kg in EPM test and increased the immobility time very significantly in FST. Hence it can be concluded that CT may be used as an alternative therapeutic agent while treating patients with anxiety and depressive disorders.
如今,焦虑症和抑郁症是最常见的疾病。它们不仅难以诊断,甚至难以治疗,因为这两种疾病有时会同时出现,或者一种会诱发另一种。除此之外,这些药物的副作用也很大;因此,草药在治疗这些疾病方面有很大的应用空间。因此,本研究旨在评估红花花瓣提取物的抗焦虑和抗抑郁作用。在卡拉奇大学药理学系动物房饲养的28只体重180 - 220克的白色白化病大鼠被随机分为四组(每组n = 7),以评估行为效应。分别在100和200毫克/千克剂量下,使用高架十字迷宫和强迫游泳试验评估红花花瓣提取物的抗焦虑和抗抑郁作用。将这些作用与标准药物地西泮(抗焦虑药)2毫克/千克和去甲替林(抗抑郁药)12.5毫克/千克进行比较。结果表明,与对照组相比,红花提取物在两个剂量下均产生了高度显著的抗焦虑和抗抑郁作用,类似于标准抗焦虑和抗抑郁药物地西泮和去甲替林。在高架十字迷宫试验中,两个剂量均非常显著地增加了首次进入封闭臂的潜伏期和在开放臂中停留的时间,而在100毫克/千克剂量下进入开放臂的次数显著增加,在200毫克/千克剂量下非常显著增加;在强迫游泳试验中,非常显著地增加了不动时间。因此,可以得出结论,红花提取物在治疗焦虑症和抑郁症患者时可作为一种替代治疗药物。